PIETER REPPENHAGEN: Open Payments
NPI 1477260701 · SALEM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 9 companies in 2025. Trend: 2023 $48 · 2024 $222 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Endo USA, Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $29 |
| Organon LLC | 1 | $27 |
| Sandoz Inc. | 1 | $20 |
| DJO, LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: ORENCIA, TRIGEN INTERTAN, XIAFLEX, TREMFYA, HADLIMA, ENBREL, TAVNEOS, HYRIMOZ.
Industry payments across NH — which companies pay providers there.
